Targeted Technology Funds
The Targeted technology Funds are focused on investing in life science companies that have the opportunity to advance ground breaking or disruptive technologies and which have the potential to significantly improve the outcomes for patients with significant medical conditions. We also favor technologies that can greatly impact the efficiency, cost or functionality of the development and manufacture of life science products. We believe that our life science investment model is particularly suited to today’s healthcare and economic environment that favors innovation which can improve clinical outcome and patient care and reduce healthcare budgets.
Targeted Technology Funds focuses specifically on life sciences, including biotechnology, medical devices, diagnostics, and specialty pharmaceuticals. They prioritize technologies that improve patient outcomes and reduce healthcare costs through innovation.
San Antonio, Texas, United States
Venture Capital and Private Equity Principals
venture capital
healthcare, biotechnology, medical devices, diagnostics, life science tools, specialty pharmaceuticals
—
—
6
2009
healthcare · life sciences, medical devices, life science tools, biotechnology, diagnostics, specialty pharmaceuticals
Done
Prospects
No prospects linked to this account.
Outreach History
Outreach sequencing tables are not yet in Supabase.